Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parathyroid Hormone | 12 | 2010 | 1800 | 0.230 |
Why?
|
| Osteoporosis | 9 | 1994 | 1579 | 0.160 |
Why?
|
| Calcitriol | 4 | 1993 | 297 | 0.150 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2010 | 315 | 0.140 |
Why?
|
| Hypercalcemia | 3 | 2010 | 409 | 0.140 |
Why?
|
| Calcium | 11 | 2010 | 5755 | 0.140 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2010 | 386 | 0.100 |
Why?
|
| Hydroxycholecalciferols | 2 | 1981 | 44 | 0.100 |
Why?
|
| Peptide Fragments | 6 | 1988 | 5096 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2010 | 2036 | 0.090 |
Why?
|
| Glucocorticoids | 3 | 2010 | 2108 | 0.080 |
Why?
|
| Hyperparathyroidism | 2 | 2004 | 339 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2010 | 623 | 0.070 |
Why?
|
| Phosphates | 3 | 1984 | 785 | 0.070 |
Why?
|
| Bone and Bones | 5 | 1984 | 2576 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 2 | 1988 | 417 | 0.060 |
Why?
|
| Bone Regeneration | 1 | 1986 | 427 | 0.060 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 772 | 0.060 |
Why?
|
| Teriparatide | 6 | 1988 | 225 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 3338 | 0.050 |
Why?
|
| Dihydroxycholecalciferols | 1 | 1981 | 17 | 0.050 |
Why?
|
| Spine | 3 | 1993 | 1144 | 0.050 |
Why?
|
| Autoimmune Diseases | 2 | 2010 | 2134 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 1984 | 1472 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2010 | 2265 | 0.040 |
Why?
|
| Hormones | 1 | 1984 | 889 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1984 | 1081 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2000 | 287 | 0.040 |
Why?
|
| Magnesium | 1 | 1981 | 813 | 0.040 |
Why?
|
| Densitometry | 2 | 1989 | 156 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2000 | 675 | 0.040 |
Why?
|
| Prostaglandins E | 2 | 1994 | 172 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 2010 | 1420 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7282 | 0.030 |
Why?
|
| Drug Resistance | 2 | 2010 | 1608 | 0.030 |
Why?
|
| Diabetic Neuropathies | 1 | 1997 | 400 | 0.030 |
Why?
|
| Diabetic Foot | 1 | 1997 | 355 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1997 | 11726 | 0.030 |
Why?
|
| Mast Cells | 1 | 2000 | 1544 | 0.030 |
Why?
|
| Bone Development | 2 | 1994 | 483 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 784 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 1997 | 818 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 326 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2010 | 39 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 2010 | 180 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 253 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2010 | 292 | 0.020 |
Why?
|
| Calcifediol | 1 | 2010 | 166 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 1997 | 984 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 326 | 0.020 |
Why?
|
| Calcium, Dietary | 2 | 1983 | 526 | 0.020 |
Why?
|
| Vitamin D | 1 | 1983 | 3224 | 0.020 |
Why?
|
| Creatinine | 2 | 2004 | 1919 | 0.020 |
Why?
|
| Kidney | 1 | 1984 | 7184 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 906 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 625 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 1997 | 1210 | 0.020 |
Why?
|
| Procollagen | 1 | 1988 | 185 | 0.020 |
Why?
|
| Lumbar Vertebrae | 2 | 1988 | 1848 | 0.020 |
Why?
|
| Minerals | 1 | 1988 | 275 | 0.020 |
Why?
|
| Hip Fractures | 2 | 1984 | 955 | 0.020 |
Why?
|
| Phosphorus | 1 | 1986 | 338 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2010 | 1463 | 0.020 |
Why?
|
| Osteitis Deformans | 1 | 1984 | 53 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 1206 | 0.010 |
Why?
|
| Bone Density | 3 | 1994 | 3468 | 0.010 |
Why?
|
| Osteocalcin | 1 | 1984 | 273 | 0.010 |
Why?
|
| Osteomalacia | 1 | 1983 | 53 | 0.010 |
Why?
|
| Aged | 12 | 2010 | 163288 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 2004 | 509 | 0.010 |
Why?
|
| Parathyroidectomy | 1 | 2004 | 235 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1983 | 420 | 0.010 |
Why?
|
| Consensus | 1 | 2010 | 2960 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1981 | 419 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1984 | 867 | 0.010 |
Why?
|
| Plasma Substitutes | 1 | 2000 | 57 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1993 | 6489 | 0.010 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 2000 | 41 | 0.010 |
Why?
|
| Nedocromil | 1 | 2000 | 46 | 0.010 |
Why?
|
| Histamine Release | 1 | 2000 | 142 | 0.010 |
Why?
|
| Humans | 21 | 2010 | 744366 | 0.010 |
Why?
|
| Hospitals, General | 1 | 1984 | 749 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
| Female | 15 | 2010 | 380193 | 0.010 |
Why?
|
| Anti-Allergic Agents | 1 | 2000 | 141 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3611 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1101 | 0.010 |
Why?
|
| Cell Size | 1 | 2000 | 643 | 0.010 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2000 | 337 | 0.010 |
Why?
|
| Middle Aged | 11 | 2010 | 213390 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1982 | 1276 | 0.010 |
Why?
|
| Male | 13 | 2000 | 350115 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2000 | 1460 | 0.010 |
Why?
|
| Glucagon | 1 | 1977 | 533 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 13991 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2010 | 4468 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 1983 | 1343 | 0.010 |
Why?
|
| Adult | 8 | 1988 | 214052 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1977 | 1154 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4561 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1984 | 2530 | 0.010 |
Why?
|
| Thiopental | 1 | 1971 | 59 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1994 | 575 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 16000 | 0.010 |
Why?
|
| Models, Structural | 1 | 1989 | 361 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2000 | 2531 | 0.010 |
Why?
|
| Calibration | 1 | 1989 | 816 | 0.000 |
Why?
|
| Kinetics | 2 | 1988 | 6476 | 0.000 |
Why?
|
| Computers | 1 | 1989 | 612 | 0.000 |
Why?
|
| Bone Resorption | 2 | 1981 | 723 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 1681 | 0.000 |
Why?
|
| Animals | 5 | 2000 | 168768 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1993 | 4933 | 0.000 |
Why?
|
| Age Factors | 1 | 1981 | 18373 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1988 | 2031 | 0.000 |
Why?
|
| Radiographic Image Enhancement | 1 | 1988 | 885 | 0.000 |
Why?
|
| Rats | 1 | 2000 | 24252 | 0.000 |
Why?
|
| Fractures, Spontaneous | 1 | 1985 | 230 | 0.000 |
Why?
|
| Diet | 1 | 1981 | 7937 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1988 | 2274 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1994 | 7914 | 0.000 |
Why?
|
| Clodronic Acid | 1 | 1982 | 60 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 20130 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1981 | 9 | 0.000 |
Why?
|
| Indomethacin | 1 | 1982 | 332 | 0.000 |
Why?
|
| Asthma | 1 | 1980 | 6010 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1971 | 4196 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 4982 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1989 | 6366 | 0.000 |
Why?
|
| Spinal Diseases | 1 | 1985 | 538 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1989 | 6459 | 0.000 |
Why?
|
| Linear Models | 1 | 1989 | 5953 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1977 | 5263 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1977 | 363 | 0.000 |
Why?
|
| Osteoclasts | 1 | 1981 | 729 | 0.000 |
Why?
|
| Cell Count | 1 | 1981 | 1856 | 0.000 |
Why?
|
| Rabbits | 1 | 1982 | 4894 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1977 | 2255 | 0.000 |
Why?
|
| Mice | 1 | 2000 | 81201 | 0.000 |
Why?
|
| Dye Dilution Technique | 1 | 1971 | 17 | 0.000 |
Why?
|
| Blood Volume Determination | 1 | 1971 | 43 | 0.000 |
Why?
|
| Sex Factors | 1 | 1985 | 10400 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1971 | 383 | 0.000 |
Why?
|
| Carcinoma | 1 | 1982 | 2375 | 0.000 |
Why?
|
| Hematocrit | 1 | 1971 | 636 | 0.000 |
Why?
|
| Blood Volume | 1 | 1971 | 565 | 0.000 |
Why?
|
| Hindlimb | 1 | 1971 | 504 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1971 | 854 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1971 | 936 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1971 | 1525 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1971 | 1423 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1971 | 845 | 0.000 |
Why?
|
| Dogs | 1 | 1971 | 3912 | 0.000 |
Why?
|
| Respiration | 1 | 1971 | 1653 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1971 | 6442 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1971 | 8551 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_